Multiple Sclerosis International (Jan 2011)

Serum Metabolic Profile in Multiple Sclerosis Patients

  • Barbara Tavazzi,
  • Anna Paola Batocchi,
  • Angela Maria Amorini,
  • Viviana Nociti,
  • Serafina D'Urso,
  • Salvatore Longo,
  • Stefano Gullotta,
  • Marika Picardi,
  • Giuseppe Lazzarino

DOI
https://doi.org/10.1155/2011/167156
Journal volume & issue
Vol. 2011

Abstract

Read online

Multiple sclerosis (MS) is a progressive demyelinating process considered as an autoimmune disease, although the causes of this pathology have not been yet fully established. Similarly to other neurodegenerations, MS is characterized by a series of biochemical changes affecting to different extent neuronal functions; great attention has been given to oxidative/nitrosative stress and to alterations in mitochondrial functions. According to previous data, MS patients show significant changes in the circulating concentrations of different metabolites, although it is still unclear whether uric acid undergoes to decrease, increase, or no change under this pathological condition. In this study, we report the serum metabolic profile in terms of purines, pyrimidines, creatinine, malondialdehyde, ascorbic acid, nitrite, and nitrate in a group of 170 MS patients. The results show increase in circulating uric acid and other oxypurines (hypoxanthine and xanthine), as well as in uridine and β-pseudouridine. The concomitant increase in circulating creatinine, malondialdehyde, nitrite, and nitrate, and decrease in ascorbic acid, demonstrates that MS induces alteration in energy metabolism and in oxidants/antioxidants balance that can be monitored in serum of MS patients.